<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04150133</url>
  </required_header>
  <id_info>
    <org_study_id>foodprep2019</org_study_id>
    <nct_id>NCT04150133</nct_id>
  </id_info>
  <brief_title>Effects and Tolerability With Clenpiq and Low Residue Diet</brief_title>
  <official_title>The Effects and Tolerability of a Prescribed Low Residue Diet the Day Before Colonoscopy on the Cleanliness of the Colon vs. the Traditional Clear Liquid, Day Before Diet With the Use of the Clenpiq Bowel Purgative</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillmont GI</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hillmont GI</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Efficacy of Clenpiq utilized per FDA labeling, with a low residue diet the day before
      colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study proposes to assess the use of a low residue diet of a prescribed nature the day
      before colonoscopy for breakfast, lunch and early dinner. Clinical outcomes utilizing the low
      residue diet will be compared to the Food and Drug Administration (FDA) approved split dose
      labeling, including the traditional clear liquid diet the day before colonoscopy utilizing
      the Clenpiq (Ferring Pharmaceuticals) bowel preparation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 21, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>single blind trial of FDA approved preparation with per labeling clear liquid diet versus a single day low residue diet</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Investigator will be ignorant of how preparation was taken</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Statistical equivalence of the clear liquid and low residue cohorts</measure>
    <time_frame>During Colonoscopy Up to 24 hours</time_frame>
    <description>Using the Boston Bowel Preparation Score, the 3 sections of the colon will be graded on adequacy of preparation at the colonoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Polyp Detection Rate</measure>
    <time_frame>Post Procedure Up to 24 hours</time_frame>
    <description>Number of polyps detected and removed per total number of patients in each arm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Colonoscopy Preparation</condition>
  <arm_group>
    <arm_group_label>Traditional Clear Liquid Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Following instructions with FDA-labeled clear liquids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Residue Diet Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following instructions for a low residue diet along with FDA-labeled clear liquids</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Residue Diet</intervention_name>
    <description>Variable cohort will eat 3 low residue meals on the day prior to their planned colonoscopy</description>
    <arm_group_label>Low Residue Diet Arm</arm_group_label>
    <arm_group_label>Traditional Clear Liquid Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All subjects age 18-80 requiring colonoscopy for appropriate indications

        Exclusion Criteria:

          -  Active diarrhea (Greater than 3 unformed stools daily)

          -  Constipation (Less than 3 spontaneous bowel movements per week) Each within 2 weeks of
             the scheduled Colonoscopy.

        Additional exclusion criteria would include;

          -  Subjects with a history of inflammatory bowel disease

          -  Colonic resection of any length

          -  Pregnant women

          -  American Society of Anesthesiologists (ASA) score greater than 3

          -  Body Mass Index (BMI) greater than 50

          -  Previous reaction to this bowel preparation or contraindications to taking Clenpiq per
             the package labeling guidelines.

          -  Subjects unable to give their own informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerald Bertiger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillmont GI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerald Bertiger, MD</last_name>
    <phone>215-402-0800</phone>
    <email>gbertiger@hillmontgi.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Edie Fletcher, RN</last_name>
    <phone>215-664-4362</phone>
    <email>efletcher@hillmontgi.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hillmont GI</name>
      <address>
        <city>Flourtown</city>
        <state>Pennsylvania</state>
        <zip>19031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edie Fletcher, BSN</last_name>
      <phone>215-664-4362</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 24, 2019</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>low residue diet</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

